Physical role limitation
Related entities
Findings (27)
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37
None
adverseMen undergoing ADT experienced statistically significant worsening in physical role limitation quality of life compared to eugonadal controls, while other QOL domains (emotional well-being, emotional
Effect: adverse; -18.28; CI: 95%CI= -30.18 to -6.37